Tirzepatide changes eating behavior and diet quality of life in type 2 diabetes patients within 3 months | Research

The takeaway

In 60 T2DM outpatients, 3 months of tirzepatide produced significant changes in eating behavior alongside weight loss and HbA1c improvement, with diet-related quality of life impacts assessed.

Eating behavior transformed
Tirzepatide significantly changed eating behavior within 3 months—understanding these changes helps clinicians support the psychological aspects of GLP-1 treatment

What the researchers found

Tirzepatide: significant changes in eating behavior at 3 months. Weight loss and HbA1c improvement. Diet-related QoL changes assessed. 60 T2DM outpatients.

Why it matters

GLP-1/GIP drugs fundamentally change how people relate to food. Understanding these behavioral changes helps clinicians provide holistic support during treatment.

How the study worked

Observational study of 60 T2DM outpatients on tirzepatide for 3 months. Eating behavior questionnaires. Body weight. HbA1c. Diet-related QoL assessment.

What this study cannot tell us

Small study (60). Short follow-up (3 months). Single center. No control group. Diet QoL tools may not capture all relevant changes.

How to read the evidence

Small observational study. Good for behavioral insights but limited generalizability.

When this study was published

Published in 2025.

The bigger picture

The behavioral aspects of GLP-1 drugs—how they change food preferences, portion sizes, and eating patterns—are as important as their metabolic effects for long-term success.

Questions still open

Do eating behavior changes persist after stopping tirzepatide?
Which specific eating behaviors change most?
Does diet QoL improve or worsen overall?

Common questions

How does tirzepatide change eating behavior?

This study found significant changes in eating patterns within 3 months of starting tirzepatide. Patients reported altered food preferences and eating behaviors alongside weight loss. Understanding these changes helps patients and their healthcare team adapt to the drug's effects on appetite and food enjoyment.

Will food still be enjoyable on tirzepatide?

Diet-related quality of life changes are part of the GLP-1 drug experience. This study formally assessed these changes, recognizing that while weight loss is the goal, how patients feel about food matters too. Working with a dietitian can help maintain food enjoyment while adapting to new appetite levels.

Read the original research

Changes in eating behavior and diet-related quality of life in individuals treated with tirzepatide for type 2 diabetes.

Diabetology international, 16(4), 648-660

View on PubMed ↗Publisher’s paper ↗

Citation

Toga-Sato, Shiori; Tosaki, Takahiro; Hodai, Yuichi; Kondo, Masaki; Miura-Yura, Emiri; Kato, Makoto; Morishita, Yoshiaki; Tsunekawa, Shin; Himeno, Tatsuhito; Kato, Yoshiro; Nakamura, Jiro; Kamiya, Hideki. (2025). Changes in eating behavior and diet-related quality of life in individuals treated with tirzepatide for type 2 diabetes.. Diabetology international, 16(4), 648-660. https://doi.org/10.1007/s13340-025-00829-7